BKD
Brookdale Senior Living Inc.
BKD lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
BKD Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
BKD's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
BKD PE Valuation
BKD has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 393x next year's earnings.
BKD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect BKD to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
BKD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.17 | +$1.14 |
| Q2 2026 | -$0.59 | +$0.46 |
| Q1 2026 | -$0.87 | +$0.17 |
| Q4 2025 | -$1.12 | -$0.23 |
| Q3 2025 | -$1.31 | -$0.39 |
| Q2 2025 | -$1.05 | -$0.13 |
| Q1 2025 | -$1.04 | -$0.27 |
| Q4 2024 | -$0.89 | -$0.05 |
BKD is still losing money, but far less than before: $0.17 per share over the past year, against $2.15 at its worst in early 2021.
BKD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $712.1M | -12% |
| Q2 2026 | $718.6M | -12% |
| Q1 2026 | $764.9M | -6% |
| Q4 2025 | $754.1M | -3.4% |
| Q3 2025 | $813.2M | +3.7% |
| Q2 2025 | $812.9M | +4.6% |
| Q1 2025 | $813.9M | +4% |
| Q4 2024 | $780.9M | +3.5% |
BKD's revenue has slid since its 2020 peak: $712M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +12 points |
| Q2 2026 | 12% | +10 points |
| Q1 2026 | 6.8% | +3.1 points |
| Q4 2025 | 3% | +3.3 points |
| Q3 2025 | -6.6% | -7.9 points |
| Q2 2025 | 1.8% | -0.6 points |
| Q1 2025 | 3.6% | +1.2 points |
| Q4 2024 | -0.3% | +2.9 points |
BKD's operating margin was 5.8% last quarter, up 12 points from the same quarter a year ago.
BKD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $25.7M | -26% |
| Q2 2026 | $43.5M | +49% |
| Q1 2026 | -$25.6M | -$7.2M |
| Q4 2025 | -$29.1M | -$24M |
| Q3 2025 | $34.9M | +204% |
| Q2 2025 | $29.1M | +610% |
| Q1 2025 | -$18.4M | +$27.1M |
| Q4 2024 | -$5.1M | +$24.1M |
BKD has burned cash in most quarters: $15M over the past year, down 64% from the year before.
BKD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.0x | High |
| Q2 2026 | 9.1x | High |
| Q1 2026 | 10.6x | High |
| Q4 2025 | 10.7x | High |
| Q3 2025 | 10.9x | High |
| Q2 2025 | 9.5x | High |
| Q1 2025 | 9.6x | High |
| Q4 2024 | 9.2x | High |
BKD's net debt is about 8.0 years of its operating earnings (EBITDA), down from 11 years a year ago.
BKD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.0 | Oversold |
| Stochastic | 6.9 | Oversold |
BKD's weekly RSI is 29 (oversold) and its Stochastic is 7 (oversold).
BKD PE vs Healthcare Sector
| Metric | BKD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BKD has no meaningful PE right now: it lost money over the past year.
BKD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.1 | 11% below |
| 20 week MA | $12.1 | 26% below |
| 50 week MA | $12.8 | 30% below |
| 100 week MA | $9.91 | 9.6% below |
| 200 week MA | $7.54 | 19% above |
BKD has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BKD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.01 | $4.21 | -40% |
| 2021 | $4.21 | $5.17 | +23% |
| 2022 | $5.17 | $2.71 | -48% |
| 2023 | $2.71 | $5.82 | +115% |
| 2024 | $5.82 | $5.07 | -13% |
| 2025 | $5.07 | $10.9 | +115% |
| 2026 YTD | $10.9 | $8.96 | -18% |
BKD's yearly returns have swung widely, from +115% in 2025 to −48% in 2022. It's down 18% so far in 2026.